PROSTIN F2 ALPHA Drug Patent Profile
✉ Email this page to a colleague
When do Prostin F2 Alpha patents expire, and when can generic versions of Prostin F2 Alpha launch?
Prostin F2 Alpha is a drug marketed by Pharmacia And Upjohn and is included in one NDA.
The generic ingredient in PROSTIN F2 ALPHA is dinoprost tromethamine. There are six drug master file entries for this compound. Additional details are available on the dinoprost tromethamine profile page.
Summary for PROSTIN F2 ALPHA
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 66 |
Clinical Trials: | 12 |
Patent Applications: | 471 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PROSTIN F2 ALPHA at DailyMed |
Recent Clinical Trials for PROSTIN F2 ALPHA
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University Medical Centre Maribor | Phase 4 |
Aswan University Hospital | N/A |
Ministry of Health, Singapore | N/A |
Anatomical Therapeutic Chemical (ATC) Classes for PROSTIN F2 ALPHA
US Patents and Regulatory Information for PROSTIN F2 ALPHA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pharmacia And Upjohn | PROSTIN F2 ALPHA | dinoprost tromethamine | INJECTABLE;INJECTION | 017434-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PROSTIN F2 ALPHA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pharmacia And Upjohn | PROSTIN F2 ALPHA | dinoprost tromethamine | INJECTABLE;INJECTION | 017434-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Pharmacia And Upjohn | PROSTIN F2 ALPHA | dinoprost tromethamine | INJECTABLE;INJECTION | 017434-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Pharmacia And Upjohn | PROSTIN F2 ALPHA | dinoprost tromethamine | INJECTABLE;INJECTION | 017434-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for PROSTIN F2 ALPHA
See the table below for patents covering PROSTIN F2 ALPHA around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Australia | 465150 | ⤷ Try a Trial | |
Denmark | 130067 | ⤷ Try a Trial | |
South Africa | 7103181 | ⤷ Try a Trial | |
Germany | 1643740 | Dihydro-PGF1ss,dessen Methylester und Methylerstertriacetat und Verfahren zur Herstellung dieser Verbindungen | ⤷ Try a Trial |
Germany | 1160981 | Verfahren zur Gewinnung von kristallisiertem PGE und PGF | ⤷ Try a Trial |
Belgium | 767926 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |